Ebola Outbreak 2014 - News, Updates and Related Investments Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ebola Outbreak 2014 - News, Updates and Related Investments

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: statesidereport	8/6/2014 1:14:48 PM
	Read Replies (1) of 608

TKM may be the better option for wide-spread use: Serum hard to mass-produce 5:00 AM Thursday Aug 7, 2014 Save Like on Facebook0 Tweet on Twitter0 Post on LinkedIn0 +1 on Google+0 The experimental drug given to two American patients with Ebola is made from tobacco leaves and is hard to produce on a large scale, a leading US doctor said. The ZMapp serum consists of three antibodies manufactured in modified tobacco leaves, which take weeks to grow. "We cannot say right now that this drug is particularly promising," said Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases. "The animal data are very good and the use of it in the two patients is suggestive that it may have a favourable effect, but since there are only two patients I think you have to be careful about making any definitive decision," he said. ZMapp was first identified as a drug candidate in January. - AFP

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next